|Articles|May 21, 2019
I-ACT for Children Selects Advarra as Central IRB
Advertisement
Advarra has announced that it has been selected by the Institute for Advanced Clinical Trials for Children to provide central institutional review board services to the organization’s pediatric clinical trial site network. I-ACT for Children currently includes 44 U.S. pediatric research sites.
For further details, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research
2
ACT Brief: AI-Enabled COA Migration, Expanding Trial Footprints into Routine Care, and New FDA Approval in Myasthenia Gravis
3
ACT Brief: New CAR-T Trial Requirements, Pfizer Advances Oral GLP-1 Strategy, and Kisqali Shows Durable Long-Term Control
4
When AI Learns to Speak Every Language: An eCOA Migration Study
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
